Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK). (Q54055764)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK). |
scientific article |
Statements
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK). (English)
1 reference
R Morant
1 reference
J Bernhard
1 reference
R Maibach
1 reference
M Borner
1 reference
M F Fey
1 reference
B Thürlimann
1 reference
E Jacky
1 reference
F Trinkler
1 reference
J Bauer
1 reference
G Zulian
1 reference
S Hanselmann
1 reference
C Hürny
1 reference
F Hering
1 reference
1 February 2000
1 reference
11
1 reference
2
1 reference
183-188
1 reference
Identifiers
1 reference